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ABSTRACT 
 
This study evaluated the anticonvulsant property of Waltheria indica leaf extract and fractions. Waltheria indica 
leaves were harvested, identified with herbarium specimen deposited, air-dried and pulverized. The pulverized 
leaves were soxhlet extracted using aqueous methanol. The crude extract was dried in vacuo. Phytochemical, 
pharmacognostic standards and toxicity evaluations were carried out. The crude extract was screened for 
anticonvulsant activity at concentrations of 250mgkg
-1
 and 500mgkg
-1
; and subsequently subjected to liquid- liquid 
partitioning with n-hexane, chloroform, n-butanol, methanol and water, to obtain the respective fractions. These 
fractions were screened for anticonvulsant activity. The most active fraction was subjected to vacuum liquid 
chromatography (VLC) and the VLC fractions screened using analytical HPLC. The leaf contains saponins (7.2%), 
alkaloids (10.2%) and flavonoids (6.8%); while proximate analysis showed moisture content of (15.83%), total ash 
(6%) and acid insoluble ash (5%). The LD50 was > 5000mgkg
-1
. Anticonvulsant evaluations showed that at 
250mgkg
-1
 chloroform showed protection of (80%), crude extract (40%), methanol fraction (40%), n-hexane (20%) 
and n-butanol (20%). At 500mgkg
-1
 chloroform fraction showed protection of (100%), crude extract (60%), 
methanol (60%), n-butanol fractions (60%) and n-hexane (40%). The HPLC screening identified phyto-compounds 
with reported anticonvulsant activity (Astragalin, p-Hydroxybenzoic acid, (z)-Oct-2-ene-1, 3, 8-tricarboxylic acid, 
(z)-2-(7-hydroxyoctyl) pent-2-enedioic acid and Septicine). Waltheria indica leaf extract is non-toxic and 
significantly delayed the onset of convulsion and onset of death due to convulsion and reduced the number of 
convulsion per minutes. The protections given were dose dependent.  This study established anticonvulsant property 
of Waltheria indica leaf, thus supports its ethnomedicinal use. 
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Introduction 
 
 
Convulsion has been a global threat. It is a children 
disease that is characterized by jerking or fitting as a 
result of abnormal electrical discharge in the brain and 
lasts for few minutes when it sets in. It can occur at 
anytime of the day and may cause death before getting 
medical attention. Much effort has been directed over 
the past years to evaluate the role of available 
anticonvulsant drugs in the management of convulsion.  
____________________________ 
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Unfortunately, valuable comparisons among various 
studies published are difficult [1]. This is because there 
are differences in the scheme of evaluation applied. 
The patient groups are not comparable in terms of age, 
onset of convulsion and treatment choice [2]. Criteria 
for evaluation of result are sometimes not indicated and 
the distribution of factors affecting the treatments is 
usually different among groups [3].Since 1990s, 
vigabatrin an inhibitor of gamma- aminobutyric acid  A   
(GABA A) receptor or GABA transminase, has been 
used and shown to be successful in  the resolution of 
infant convulsion, especially for those associated with 
tuberous sclerosis and has been a first line therapy, but 
its potential association with irreversible visual field 
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study to identify has restricted its use in certain parts of  
the  world [4], however, alternative treatment including  
Alum sativum , Telferia  occidentalis and Cassy thafili, 
Waltheria indica has been used locally. Although these 
were not yet evaluated, they have been used with 
variable success. Apart from the fact that, they have not 
all been evaluated but locally they have given success 
to the herbalist. In traditional medicine Waltheria 
indica has been used in various treatment of infection; 
however, the relevant pharmacological bases for these 
indications are often missing in traditional medicines. 
Decoction is used in the treatment of convulsion, 
wounds, skin ulcer, rheumatism and cancer [5]. 
Maceration and juices were mostly used to treat eye 
diseases [6]. Infusion of the leaves or roots was used to 
treat gingivitis and anemia [7]. Chewing of the root is 
also used by some populations. The root is chewed by 
Bissa community in Burkina-Faso against sore throat 
and to treat internal haemorrhage [8]. Waltheria indica 
is used for the treatment of minor ailments (e.g. sore 
throat, cough, erectile dysfunction) and complicated 
ailments (like inflammation and asthma). In Hawaii, 
Waltheria indica is considered as one of the ten most 
recognized medicinal plants. Locally, it is used as 
aspirin-like anti-inflammatory drugs [9]. In this regard 
various extracts are used in the management of 
inflammation and inflammatory conditions. Waltheria 
indica is used in the treatment of diarrhea by traditional 
healers in Nigeria [10]. In addition, it is traditionally 
used to treat malaria, dysentery, haemorrhoids, leprosy 
and epilepsy [11], infertility and bladder ailments [12], 
erectile dysfunction and impotence [13].The search for 
alternative drug to use in convulsion, at what duration 
and the evaluation of the efficacy is the cardinal point 
and is of great research interest.  It is a considerable 
fact that convulsion occurs spontaneously; therefore 
the absence of anticonvulsant drug can lead to major 
complications such as brain damage or death. Not 
every drugs used for convulsion management are 
allowed to sell locally. This research was carried out 
with the view to determining the anticonvulsant 
property of the leaf extract and fractions of Waltheria 
indica; and to ascertain its mechanism of action by 
determining the constituents responsible for this 
activity. Waltheria indica plant is of the kingdom 
Plantae, super-division Embroyophyta, division 
Tracheophyta, sub-division Spermatophytina, class 
Magnoliopsida, sub-order Rosanae, order Malvales, 
family Malvaceae, genus Waltheria and species 
Waltheria indica. 
 
 
 
Fig 1: Picture of Waltheria indica leaves 
 
Methods 
 
Plant collection: A fresh Waltheria indica plant was 
collected in June, 2014 in an abandoned farm land in 
Ebonyi state. Its taxonomic identification was 
confirmed by Prof. B.A. Ayinde. The leaves were 
removed and air dried for four weeks and oven dried 
for two hours before blending with a milling machine. 
Extraction: 1100 gram of the powdered sample 
Waltheria indica leaf was soxhlet extracted using 
methanol. The extract was concentrated using rotary 
evaporator under reduced pressure. The concentrated 
sample was dried, stored   and the yield determined. 
Phytochemistry and proximate analysis of Waltheria 
indica leaf extract: Phytochemical screening and 
proximate analysis were carried out on the leaf to 
determine the presence of some phyto-compounds and 
admixtures in the sample according [14, 15]. In this 
process, the following were determined: Moisture 
content, total ash, acid insoluble ash, water soluble ash 
and water soluble extractive. 
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Determination of moisture content  
An evaporating dish which has been heated to constant 
weight and stored in desiccator was taken. A 3 g of 
powdered Waltheria indica leaf was accurately 
weighed into the dish. It was placed in an oven set at 
100-105 
0
C and was dried for 5 hours and the sample 
was weighed again. The drying and weighing was 
continued at one hour intervals till the difference 
between two successive weighing corresponded to not 
more than 0.25 %. Constant weight was reached when 
two consecutive weighing after drying for 30 minutes 
and cooling for 30 minutes in a desiccator showed not 
more than 0.01 g difference. The moisture content was 
the total weight lost expressed as the percentage of the 
initial weight of sample. 
 
 
% moisture content:
 1
100
 x 
sample powdered  theofweight  
dish  gevaporatinempty  of weight - weight averagein  Difference  
 
 
Determination of total ash  
The nickel crucible which has been heated, cooled and 
stored in a desiccator was taken a 2 g of powdered 
sample of Waltheria indica leaf was weighed into it. 
The powdered sample was spread in an even layer. It 
was heated gently in the fume cupboard till all the 
moisture has been driven off and the material has been 
completely charred. The flame was gradually increased 
to (450 
0
c) until the residue was completely white 
indicating that it was free from carbon, and then it was 
cooled and weighed. It was continued with reference to 
air dried sample. It was carried out in triplicate.  
Percent total ash:
 
1
100
 x 
sample dried ofweight  
 crucible of wt Initial - crucible  sample of weight  
 
 
Determination of acid insoluble ash 
The total ash obtained after burning the sample in a 
crucible was mixed with 25 ml of dilute hydrochloric 
acid and allowed to stand for 5 minutes covering the 
crucible with a watch glass. It was filtered to collect 
the insoluble matter on an ash-less filter paper. Later, 
the watch glass and crucible was washed in a hot 
water and was passed through the filter paper. The 
washing was continued till the insoluble matter was 
completely free from acid (i.e. until the filtrate was 
neutral) and the solid on the tip of the edge of the filter 
paper was washed. Acid insoluble ash was expressed 
as weight differences in reference to the initial weight 
of the sample. 
 
                                           Percent acid insoluble ash:
 1
100
 x 
 sample dried ofweight  
 difference weight  
 
Determination of water soluble ash  
The ashed sample was put in a crucible and was mixed 
with 25 ml of water. It was boiled for 5 minutes. Then 
it was filtered into a beaker and put back into a glass 
crucible. The insoluble matter in a glass crucible and 
filter paper was washed with a hot water, and ignited in 
the crucible for 15 minutes at a temperature not more 
than 450
0
c. The weight of this residue was subtracted 
from the weight of the total ash. The content of water 
soluble ash was calculated in reference to the air dried 
sample. 
                                     Percent water soluble ash:
 1
100
 x 
sample dried  theofweight  
ash   total- crucible of weight Final  
 
Determination of water soluble extractives  
A 5 g of Waltheria indica leaf powder was accurately 
weighed into a stoppered conical flask. A 100 ml of 
water was added into the conical flask and firmly 
covered and macerated for 24 hours. It was shaken for 
6 hours by placing the flask on the mechanical shaker 
and allowed to shake slowly and after 6 hours, the flask 
was removed and allowed to stand for further 18 hours. 
It was filtered rapidly, taking precautions against loss 
of filtrate. A 25 ml of the filtrate was evaporated to 
dryness in a tarred flat-bottomed evaporating dish. It 
was then dried to constant weight at 105 
0
C in the oven 
and weighed again. The percentage water –soluble 
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extractive was calculated with reference to the air- 
dried sample. The experiment was carried out in 
triplicates. 
 
Percent water soluble extractive:
 1
100
 x 
sample dried ofweight  
dish empty  of weight - sample dish  gevaporatin of weight  
 
 
Acute toxicity test: A 5 gram of concentrated extract 
was reconstituted using Tween 80 and used to carry out 
acute toxicity test. A total of 9 rats were used for each 
phase, while feeding of the animals were withdrawn 12 
hours before the experiment to determine the safety of 
the drug. Each phase took 24 hours with first phase 
taking  10 m/kg, 100 m/kg and 1000 m/kg of the 
extract while phase two took 2000, 3000 and 5000 
m/kg of the extract based on their body weight [16]. 
 
In vivo anticonvulsion assay of the crude extract: 
The crude extract was screened for anticonvulsion 
activity using the method described by Abubakar and 
Adelaiye, 2008; using 25 rats grouped into 5. The 
crude extract was administered to the animals orally in 
three concentrations of 125 mg/kg, 250 mg/kg and 500 
mg/kg of their body weight. One hour later 120 mg/kg 
of pentylenetetrazole (PTZ) was administered 
intraperitoneally. The time of administration of PTZ, 
onset of action, duration of convulsion, onset of death 
were noted and the result obtained was expressed as 
MEAN + SEM. Also, the percentage death and 
percentage protection were calculated [17]. 
In vivo anticonvulsion assay of the fractions 
A portion of the crude extract (3/4) was partitioned 
using n-hexane, chloroform, n-butanol, methanol and 
water. The respective fractions were concentrated and 
used to carry out anticonvulsant test using (Abubakar 
and Adelaive, 2008) method. A total of 60 rats, divided 
into the groups of five were used. Each fraction was 
administered to the animals orally in two concentration 
of 250 mg/kg and 500 mg/kg of their body weight. One 
hour later 120 mg/kg of PTZ was administered 
intraperitoneally. The time of administration of PTZ, 
onset of action, duration of convulsion, onset of death 
were noted and the result obtained was expressed as 
MEAN + SEM. Also, the percentage death and 
percentage protection were calculated.  
Vacuum Liquid Chromatography (VLC): VLC was 
carried out on the most active chloroform fraction 
using gradient chloroform: ethyl acetate solvent mix 
according to [18] method. The column was eluted with 
gradient chloroform/ ethyl acetate solvent system (10:0 
to 0:10 ratios). 
Bulking of fractions by thin layer chromatography 
(TLC) of the VLC fractions: The different fractions 
of VLC were spotted on TLC plates that have been 
activated in an oven set at 150 degree centigrade for 5 
minutes. It was allowed to dry before dipping each into 
the TLC tank containing n-hexane and ethyl acetate 
solvent mix (in the ratio of  140:60), pre- saturated with 
the solvent system vapour. The TLC plate was allowed 
to develop. The TLC plate was removed; allowed to 
dry before spraying with concentrated tetraoxosulphate 
(VI) acid and was viewed in ultra-violet light chamber. 
The fractions of VLC were bulked according to their 
similarities as viewed through ultra-violet light 
chamber. The bulked fractions were subjected to 
analytical HPLC for effective detection of compound 
present in each fraction. 
Analytical High performance liquid 
chromatography (HPLC) screening of the VLC 
fractions 
In the HPLC screening, 2 mg each of the VLC 
fractions was reconstituted with 2 ml of HPLC grade 
methanol. The mixture was sonicated for 10 minutes 
and thereafter centrifuged at 3000 rpm for 5 min. 100 
µL of each dissolved sample was transferred into 
HPLC vials containing 500 µL of HPLC grade 
methanol. HPLC analysis was carried out on the 
sample using a Dionex P580 HPLC system coupled to 
a photodiode array detector (UV3440S, Dionex Softron 
GmbH, Germering, Gremany). Detection was at 235, 
254, 280 and 340 nm. The separation column (125 x 4 
mm; length x internal diameter) was prefilled with 
Eurospher-10 C18 (Knauer, Germany), and a linear 
gradient of nano-pure water adjusted to pH 2 by 
addition of formic acid and methanol was used as 
eluent. 
Statistical analysis of results: The statistical 
significance was evaluated using one way analysis of 
variance (ANOVA). The values were expressed as 
mean ± standard error of mean (SEM). P ≤ 0.05 was 
considered statistically significant. 
 
Results 
 
Percentage Yield: The percentage yield was calculated at the end of the extraction, concentration and drying, using 
the expression below:  
 
Asian Pac. J. Health Sci., 2017; 4(2):61-75                                                e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Igwebuike et al            ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2017; 4(2):61-75 
www.apjhs.com                  65 
 
Percentage (%) yield =
1
100
 x 
sample powdered  theofweight  
(g)in extract    theof weight  
The yield was 220g crude extract (from the 1100g of the dried pulverized leaves), showing a percentage yield of 
20% 
Result of qualitative phytochemical screening: Table 1 below shows the result of qualitative phytochemistry 
screening of Waltheria indica leaf. 
Table 1: Result of the phytochemical of Waltheria indica leaf 
 
Alkaloids  Saponins  Tannins  Flavonoids  Steroids  Terpenoids  Cardiac glycosides  Proteins  
 + +  + + +  + +  + + + +  -  + +  -  
Key: + = Trace or mildly present, + + = Moderately present, + + + = Abundantly present, - = Absent   
Result of quantitative phytochemical screening: Table 2 below shows the result of the quantitative phytochemical 
screening of the leaf extract of Waltheria indica leaf. 
 
 
 
Table 2: Result of quantitative phytochemical screening 
 
Phyto-constituents Percentage 
Alkaloids 10.2 
Flavonoids 6.8 
Saponins 7.2 
Tannins 0.2 
Acute Toxicity Test: The results of the acute toxicity tests are presented in Tables 3 and 4. 
Table 3: Acute toxicity Test: Phase 1 
 
Groups Wt of animals in (g) Dosage in mg/kg Dosage in ml No of Death 
1 32.9(sterile water) 10 0.34 0/3 
2 33.6(crude extract) 10 0.34 0/3 
3 37.9(sterile water) 100 0.38 0/3 
4 38.8(crude extract) 1000 0.39 0/3 
 
Table 4: Acute Toxicity Test: Phase 2 
 
Groups Wt of animals in (g) Dosage in mg/kg Dosage in ml No of Death 
1 32.9(normal saline) 10 0.34 0/1 
2 39.5(crude extract) 2000 0.62 0/1 
3 40.8(crude extract) 3000 0.80 0/1 
4 43.7(crude extract) 5000 0.88 0/1 
 
Results of proximate analysis of Waltheria indica leaf: The results of the proximate analysis of Waltheria indica 
leaf is presented in Table 5. 
 
Table 5: Proximate analysis of Waltheria indica leaf extract 
 
Parameters Percentage 
Total ash 5.80 
Acid insoluble ash 5.00 
Water soluble ash 1.50 
Moisture content  15.83 
Water soluble extractive value 0.60 
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Anticonvulsant Activity: Result of anticonvulsant activity of Waltheria indica leaf extract is presented in Table 6. 
It showed the anticonvulsant activity of Waltheria indica leaf extract on PTZ induced convulsion in rat.  
 
Table 6: Anticonvulsant activity of Waltheria indica leaf extract 
 
Group Pre- 
treatment 
Dose 
mg kg
-1
 
Time of 
administration 
(minutes) 
Onset of 
action 
(minutes) 
Duration 
of 
convulsion 
(minutes) 
Onset of 
death 
(minutes) 
No of 
Death 
No of 
alive 
1 NC 5 ml 9.00+0.01 9.01+0.02 59.01+0.45 0.01+0.01 5 0 
2 
 
HF 250 9.07+0.01 9.08+0.01 53.41+1.36 0.01+0.03 4 1 
 500 9.07+0.01 10.09+0.04 51.61+0.92 0.02+0.01 3 2 
3 CF 250 9.18+0.01 9.22+0.01 39.82+2.81 0.08+1.09 1 4 
 500 9.32+0.02 9.41+0.03 35.22+2.51 - - 5 
4 BF 250 9.58+0.08 9.60+0.09 52.62+0.92 0.02+0.01 4 1 
 500 10.05+0.01 10.07+0.03 50.82+1.32 0.02+0.02 2 3 
5 MF 250 10.13+0.02 10.18+0.03 55.21+0.92 0.05+0.01 3 2 
 500 10.18+0.01 10.22+0.01 49.27+3.19 0.04+0.00 2 3 
6 AF 250 10.32+0.01 10.33+0.01 55.21+1.39 0.01+0.00 4 1 
 500 10.42+0.02 10.44+0.04 53.62+0.92 0.02+0.02 3 2 
7 Valium  5 10.50 +1.10 5.0+1.20 35+0.10 - - 5 
Key: NC= Negative control (Tween 80), HF= n-Hexane fraction, CF= Chloroform fraction, BF= Butanol fraction, 
MF= Methanol fraction, AF= Aqueous fraction and Valium= Positive control. Observation was taken on the time of 
administration of the drug, the on-set of action, duration of convulsion and on-set of death; all calculate in minutes 
and expressed as mean + SEM and analyzed using ANOVA; where values of p < 0.05 were considered statistically 
significant. 
Analytical HPLC analysis results 
The analytical HPLC results were assessed using UV scan at 235nm. This was because most of the components 
were detected best at this wavelength compared to wavelengths of 254nm, 280nm and 340nm at which the detection 
was also evaluated. The HPLC chromatogram of each fraction showed that the chromatogram obtained at 235nm 
had more compounds detected than those obtained at the other three wavelengths at which this screening was 
equally carried out.The HPLC machine had an in in-built library of UV scans of compounds with which it compares 
the UV scans of the component of each fraction eluted; and the comparison expressed as hit. Based on the similarity 
with data in an inbuilt library (hit values), the close comparison of the UV scans of the component and that of the 
library; and the literature review of the UV scan; the following compounds were preliminarily identified. Table 7 
below shows the summary of preliminarily identified compounds. 
 
Table 7: Summary of preliminarily identified compounds 
 
Fractions Comparable Peak 
VLC F1 A= Astragalin 
VLC F2 A= (12-0-deacetyl -12-epi-scalarin), B= (P-hydroxybenzoic acid), C= (protocatechus, ure), D= 
((z) –oct-2-ene- 1, 3, 8 tricarboxylic acid), E= (Tensidol B), F= (4-hydroxybezoyl – 
deltalactame) and G= (Dipiperamide). 
VLC F3 A= (Citreonigrin) and B = (z) – 2- (7-hydroxybenzoic) pent -2- enedioic acid). 
VLC F4 A= (Septicine) and B= (Scalarolide) 
Key: VLC F1 to VLC F4= Vacuum liquid chromatographic fractions 1 to 4. 
 
The analytical HPLC chromatograms of the vacuum liquid chromatographic fractions are presented in Figures 2, 4, 
7 and 9 for fractions 1- 4 respectively. The corresponding UV scan or spectrum for each component of each fraction 
are presented in Figures 3, 5 and 6, 8 and 10 respectively for fractions 1- 4. 
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Fig 2: HPLC Chromatogram of VLC F1 showing A= (Astragalin) 
 
 
Fig 3: UV spectra of Astragalin detected in VLC F1 
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Fig 4: HPLC Chromatogram of VLC F2 showing A (12-0-deacetyl -12-epi-scalarin), B (P-hydroxybenzoic 
acid), C (protocatechus, ure), D ((z) –Oct-2-ene- 1, 3, 8 tricarboxylic acid), D (Tensidol B), F (4-hydroxybezoyl 
– deltalactame) and G (Dipiperamide). 
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Fig 5: UV scans of detected components of the HPLC chromatogram of VLC F2 (UV spectra of 12-o-deacetyl 
-12-epi- scalarin, P-hydroxybenzoic acid, protocatechus, ure, (z) – Oct-2-ene- 1, 3, 8 tricarboxylic acid) 
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Fig 6: UV scan of detected components of the HPLC chromatogram of VLC F2 (UV spectra of Tensidol B, 4-
hydroxybenzoyl–deltalacteme and dipiperamide). 
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Fig 7: HPLC Chromatogram of VLC F3 showing A= (Citreonigrin) B = (z) – 2- (7-hydroxybenzoic) pent -2- 
enedioic acid) 
 
 
 
 
Fig 8: UV spectra of citreonigrin I and (z) -2- (7–hydroxyoctyl) pent -2-enedioic acid detected in VLC F3 
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Fig 9: HPL chromatogram of VLC F4 showing A= (Septicine) and B= (Scalarolide) 
 
 
 
 
 
 
Fig 10: UV spectra of septicine and scalarolide detected in VLC F4 
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Discussion 
 
The results of qualitative analysis in (Tables 1) showed 
that Waltheria indica leaf extract contained saponins, 
flavonoids, alkaloids, tannins, steroid and cardiac 
glycoside. This result was similar to that obtained by 
[19], [20]. The results of quantitative analysis of the 
crude extract of Waltheria indica leaf (Table 2) showed 
that Waltheria indica leaf extract contains saponins 
(7.2%), flavonoids (6.8%), alkaloids (10.2%), tannins 
(0.2%). Alkaloids have been reported and known for 
their central nervous system depressant activity [21]. 
Steroids have equally been reported for its use as an 
anticonvulsant and in the treatment of erectile 
dysfunction [22].In the median lethal dose test (Tables 
3 and 4); the result indicated no death in the two phases 
of the test. The LD50 was thus established to be > 5000 
mg/kg and the sample is hence considered   relatively 
non-toxic and safe for use and supports its uses in 
ethnomedicines.The results of proximate analysis of 
Waltheria indica leaf (Table 5) showed total ash 
(5.8%), acid insoluble ash (5.0 %), water soluble ash 
(1.50%), moisture content (15.83%) and water soluble 
extractive is (0.60%). In this result, moisture content of 
(15.83 %) could be considered high and could be 
responsible for its easy microbial infestation [23]. The 
ash value of (5.8 %) indicates that the plant leaf is of 
considerable quality [24]. Water soluble ash of (1.5 %) 
equally supports the good quality of the plant leaf. The 
methanol crude extract of the leaf of Waltheria indica 
showed central nervous system depressant activity 
(Table 6). The result of this study showed that 
Waltheria indica leaf extract possessed anticonvulsion 
property. In general, the chloroform fraction of the leaf 
extract of Waltheria indica plant was found to be most 
active in the protection from death due to the 
pentylenetetrazole (PTZ) induced convulsion, as shown 
in Tables 6. The anticonvulsant activity was dose 
dependent, as it varied with the doses of the extract and 
fractions administered in the different groups. The 
chloroform fraction showed protection of (80 %) at 250 
mg kg
-1
 and (100 %) at 500 mg kg
-1
, followed by 
methanol fraction with (40 %) protection at 250 mg kg
-
1
 and (60 %) at 500 mg kgm,
-1
  butanol fraction gives 
(20 %) protection at 250 mg kg
-1
 and (60 %) at 500 
mgkg
-1
 while n-hexane showed (20 %) protection at 
250 mg kg,
-1 
  and 40 % at 500 mg kg
-1
 and  aqueous 
extract showed protection of (20 %) at 250 mg kg,
-1 
  
and 40 % at 500 mg kg.
-1
 . Although, all the fractions 
protected the rat to varying degree in each case; some 
were more effective than the other. This effectiveness 
is attributed to the difference in solvent polarity 
because chloroform  is moderately polar with   polarity 
index of 4.1  [25] it mainly extracts steroids and 
alkaloids, and this played a major role in the 
management of convulsion as it acts through 
hypothalamic – pituitary adrenal axis, to stimulate 
glucocorticoid synthesis. Glucocorticoids are thought 
to interact with central nervous system steroid 
receptors that act with central nervous system steroid 
transcriptional regulator to influence voltage-dependent 
calcium channels. It may stimulate neuro-steroid 
synthesis in cells neurons, such as deoxycorticosterone 
(DOC) and tetrahydrodeoxy– corticosterone (THDOC) 
both are allosteric modulators of GABAA receptors 
[21] .The effectiveness also increases with the increase 
in the dosage of the drug. This shows that further 
increase in the dose above 500 mg/kg may completely 
protect the rat from death or from convulsing at all.  
The chloroform fraction of the leaf extract at 500 
mgkg
-1
 was found to have completely prevented death 
of animals resulting from PTZ induced convulsion; a 
finding which is similar to the finding of [17], that 
aqueous ethanolic extract of aerial portion of Waltheria 
indica plant completely prevented death of animal due 
to penthylenetetrazole induced convulsion but failed to 
protect convulsion due to strychnine suggesting 
differences in their mechanism of action. However, this 
study disagreed with the assertion that most drug with 
anticonvulsant property do not counteract 
penthylenetetrazole convulsion but retards them [26]. 
The analytical HPLC result revealed the presence of 
the following compound astragalin, a good antioxidant 
[27]; 12-0-deacetyl -12-epi-scalarin, an inhibitor [28], 
sediative  [29]; P-hydroxybenzoic acid, an antibacterial 
[30],  antimalarial [31]; protocatechus,ure, an 
antisychotic  [32]; (z) – oct -2- ene- 1,3,8 carboxylic 
acid, an inhibitor [33]; tensidol B, an 
antischizpherenial, delusion [34]; 4-
hydroxybenzoyldeltalactame, an anti-allergic [35], an 
antibiotic [36]; dipiperamide E, an inhibitor of drug 
metabolism [37];  Citreonigrin I, a cytotoxic agent 
[38];  Septicine, an anticonvulsant and muscle relaxant 
[39] and scalarolide, an antitumor [40]. These 
preliminarily identified compounds from Waltheria 
indica leaf extract could be acting synergistically in 
conferring the plant leaf its observed anticonvulsant 
activity and responsible its various ethnomedicinal 
uses. 
 
Conclusion and recommendations 
 
In conclusion, the results of qualitative, quantitative 
phytochemical and physicochemical analyses have 
shown that Waltheria indica leaf extract is a potential 
crude drug of a considerable quality that could be used 
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in the management of convulsion and other related 
cases. The extract of Waltheria indica leaf delayed the 
on-set of convulsion and prolonged on set of death due 
to pentylenetetrazole (PTZ) induced convulsion. The 
result of the study equally showed that Waltheria 
indica leaf extract contained relevant phytocompounds 
which are active against pentylenetetrazole (PTZ) 
induced convulsion, hence supports the ethnomedicinal 
use of the plant as an anticonvulsant agent. The 
findings of the study have established anticonvulsion 
property of the plant leaf, hence, the data obtained will 
add to the large body of evidence collected 
scientifically to show the immense potentials of 
medicinal plants use in various traditional medicine 
systems.  
 
Recommendation 
 
In recommendation, further study is required in order 
to establish the mechanism of action of the leaf extract 
on the central nervous system and for more detailed 
and conclusive characterization of the leaf extract.  
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